Marlowe (LON:MRL) Stock Rating Reaffirmed by Berenberg Bank

Marlowe (LON:MRLGet Rating)‘s stock had its “buy” rating reissued by stock analysts at Berenberg Bank in a research note issued to investors on Wednesday, reports. They presently have a GBX 1,160 ($13.72) price objective on the stock. Berenberg Bank’s target price points to a potential upside of 101.39% from the company’s current price.

Marlowe Stock Down 6.5 %

Shares of MRL opened at GBX 576 ($6.81) on Wednesday. Marlowe has a 52-week low of GBX 576 ($6.81) and a 52-week high of GBX 1,094 ($12.94). The company has a market capitalization of £552.26 million and a PE ratio of 57,600.00. The stock has a fifty day simple moving average of GBX 754.86 and a two-hundred day simple moving average of GBX 775.99. The company has a quick ratio of 0.85, a current ratio of 1.13 and a debt-to-equity ratio of 36.88.

Insider Activity

In other Marlowe news, insider Charles Skinner bought 16,556 shares of the firm’s stock in a transaction that occurred on Thursday, November 24th. The stock was purchased at an average price of GBX 604 ($7.14) per share, for a total transaction of £99,998.24 ($118,243.16).

Marlowe Company Profile

(Get Rating)

Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk & Compliance; and Testing, Inspection & Certification. It offers health and safety, HR and employment law compliance, occupational health, and risk management software; a range of fire safety and security services; and integrated water treatment, hygiene, testing, monitoring, wastewater, and engineering services.

See Also

Receive News & Ratings for Marlowe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marlowe and related companies with's FREE daily email newsletter.